Antiplatelet and antithrombotic activities of salvianolic acid A

被引:168
作者
Fan, Hua-Ying [1 ,2 ,3 ]
Fu, Feng-Hua [1 ]
Yang, Ming-Yan [3 ]
Xu, Hui [1 ,3 ]
Zhang, Ai-Hong [3 ]
Liu, Ke [1 ,2 ,3 ]
机构
[1] Yantai Univ, Sch Pharm, Yantai 264005, Shandong, Peoples R China
[2] Jilin Univ, Coll Life Sci, Changchun 130012, Jilin, Peoples R China
[3] Shandong Target Drug Res Co Ltd, Yantai 264005, Shandong, Peoples R China
关键词
Antiplatelet; Antithrombotic; Coagulation; Hemorheology; Salvianolic acid A; BLOOD-VISCOSITY; IN-VITRO; THROMBOSIS; INHIBITION; MECHANISMS; PLATELETS; DANSHEN; EVENTS;
D O I
10.1016/j.thromres.2010.04.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Salvianolic acid A (SAA), the water-soluble phenolic acids in Salvia miltiorrhiza, has shown the most potent bioactivities, including protection against cerebral lesion, defense from oxidative damage and improvement of remembrance. In the present study, we studied the antiplatelet and antithrombotic effects of a newly synthesized SAA with different methods both in vitro and in vivo. Materials and Methods: We tested the effect of antithrombotic activity of SAA in arterio-venous shunt model. The effects of SAA on adenosine diphosphate (ADP)-, Thrombin-, Arachidonic acid-induced rat platelets aggregation were tested both in vivo and in vitro. The activity of SAA on washed human platelet aggregation was determined by ADP stimulation. We also evaluated its property of modulation of hemorheology, assessed its bleeding side effect by measuring coagulation parameters after intravenous administration for 5 days and investigated the potential mechanisms underlying such activities. Results and Conclusions: In vivo, SAA significantly reduced thrombus weight in the model of arterio-venous shunt. Meanwhile, SAA increased plasma cAMP level determined by radioimmunoassay in the same model. Intravenously administrated SAA (2.5-10 mg/kg) inhibited platelet aggregation induced by ADP in a dose-dependent manner. Notably, SAA did not affect coagulation parameters in rats after intravenous administration SAA for successive 5 days. In vitro, pretreatment with SAA on washed rat and human platelets significantly inhibited various agonists stimulated platelet aggregation and caused an increase in cAMP level in platelets activated by ADP. These findings support our hypothesis that SAA possesses antithrombotic activities. The antithrombotic effect might be related to its antiplatelet action and ability to modulate hemorheology without affecting coagulation system. The mechanisms underlying such activities may involve the induction of cAMP. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:E17 / E22
页数:6
相关论文
共 35 条
[1]   P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries [J].
André, P ;
Delaney, SM ;
LaRocca, T ;
Vincent, D ;
DeGuzman, F ;
Jurek, M ;
Koller, B ;
Phillips, DR ;
Conley, PB .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (03) :398-406
[2]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[3]   Antiaggregatory, antithrombotic effects of MS-180, a novel platelet glycoprotein IIb/IIIa receptor antagonist [J].
Banno, H ;
Kawazura, H ;
Yutaka, T ;
Sakuma, N ;
Kitamori, T ;
Hosoya, J ;
Kibayashi, K ;
Yamashita, H ;
Umemura, K ;
Nakashima, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 367 (2-3) :275-282
[4]  
Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435
[5]   EFFECTS OF INORGANIC IONS + OF PLASMA PROTEINS ON AGGREGATION OF BLOOD PLATELETS BY ADENOSINE DIPHOSPHATE [J].
BORN, GVR ;
CROSS, MJ .
JOURNAL OF PHYSIOLOGY-LONDON, 1964, 170 (02) :397-&
[6]   Thromboxane A(2) synthase inhibition and thromboxane A(2) receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets [J].
Chang, TS ;
Kim, HM ;
Lee, KS ;
Khil, LY ;
Mar, WC ;
Ryu, CK ;
Moon, CK .
BIOCHEMICAL PHARMACOLOGY, 1997, 54 (02) :259-268
[7]  
Chen XP, 2007, CHIN J HEMORH, V17, P525
[8]   Cardiovascular effects of Danshen [J].
Cheng, Tsung O. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 121 (01) :9-22
[9]   Danshen: What every cardiologist should know about this Chinese herbal drug [J].
Cheng, Tsung O. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 110 (03) :411-412
[10]   Danshen: A versatile Chinese herbal drug for the treatment of coronary heart disease [J].
Cheng, Tsung O. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 113 (03) :437-438